| Name | Title | Contact Details |
|---|---|---|
Heather Clark |
Sr Director, HR Business Partner | Profile |
Greg Fly |
Vice President Procurement Global RandD | Profile |
Jacques Goldenberg |
Interim VP HR, RandD, Global Partnering and HR Lead of Epizyme integration | Profile |
Christelle Huguet |
Head of Research, External Innovation and Early Development | Profile |
Jennifer Glennon |
Vice President, Chief of Staff, Head of Finance, Research and Development at Ipsen | Profile |
Agadia is a Parsippany, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, or NASH, and other chronic liver diseases. Terns` programs are based on clinically validated and complementary mechanisms of action to address the multiple hepatic disease processes of NASH in order to drive meaningful clinical benefits for patients. Terns` investors include OrbiMed, Vivo Capital, Lilly Asia Ventures, and Decheng Capital.
Baxter Pharmaceutical Products is a New Providence, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Through its proprietary patented technology, Organic Potash Corporation produces 99%+ pure potassium carbonate (potash) from the ash of agricultural waste, in particular, cocoa husks. The purity of the company’s potassium carbonate will allow Organic Potash Corporation to target multiple industries including the Agricultural and Pharmaceutical industry. Organic Potash Corporation is headquartered in Toronto, Ontario and its shares trade on the Canadian National Stock Exchange under the trading symbol “OPC”.